AllianceBernstein’s Foghorn Therapeutics FHTX Stock Holding History

AllianceBernstein’s Portfolio FHTX Stock Details FHTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$144K	Hold	26,660	–	–	﹤0.01%	3118
2025 Q4	$144K	Hold	26,660	–	–	﹤0.01%	3126
2025 Q3	$130K	Buy	26,660 +1,610	+6%	+$8.54K	﹤0.01%	3152
2025 Q2	$118K	Buy	25,050 +7,670	+44%	+$32.1K	﹤0.01%	3151
2025 Q1	$63.4K	Hold	17,380	–	–	﹤0.01%	3110
2024 Q4	$82K	Hold	17,380	–	–	﹤0.01%	3143
2024 Q3	$162K	Buy	17,380 +2,790	+19%	+$20.2K	﹤0.01%	3066
2024 Q2	$83.9K	Buy	14,590 +4,540	+45%	+$27K	﹤0.01%	3136
2024 Q1	$67.4K	Hold	10,050	–	–	﹤0.01%	3062
2023 Q4	$64.8K	Sell	10,050 -700	-7%	-$3.02K	﹤0.01%	3111
2023 Q3	$53.8K	Buy	10,750 +690	+7%	+$5.32K	﹤0.01%	3132
2023 Q2	$70.8K	Buy	+10,060	New	+$70.3K	﹤0.01%	3108

Other funds holding FHTX

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

AllianceBernstein's FHTX Position: Q1 2026 in Review

AllianceBernstein held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 26,660 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #3118.

AllianceBernstein first reported a position in FHTX in Q2 2023 and has held it in 12 quarters since. The position peaked at $162K in Q3 2024. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

AllianceBernstein held 26,660 shares of Foghorn Therapeutics worth $144K as of Q1 2026.
AllianceBernstein left its Foghorn Therapeutics share count unchanged in Q1 2026.
Foghorn Therapeutics made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #3118 holding.
AllianceBernstein first reported a position in Foghorn Therapeutics in Q2 2023 and has held it in 12 quarters since.
AllianceBernstein's Foghorn Therapeutics position peaked at $162K in Q3 2024.
105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.